New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.
Background: The clearest advantage of new generation, atypical antipsychotics is a reduced risk of extrapyramidal side-effects (EPS), compared with conventional compounds. These findings might have been biased by the use of the high-potency antipsychotic haloperidol as a comparator in most of the tr...
| Published in: | Lancet Vol. 361; no. 9369; pp. 1581 - 1590 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | research systematic review tables/charts Journal Article |
| Published: |
Lancet
5/10/2003
|
| Online Access: | View this record in EBSCOhost |